Soa Wealth Advisors, Llc. Akero Therapeutics, Inc. Transaction History
Soa Wealth Advisors, Llc.
- $517 Million
- Q3 2024
A detailed history of Soa Wealth Advisors, Llc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Soa Wealth Advisors, Llc. holds 102 shares of AKRO stock, worth $2,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102
Previous 102
-0.0%
Holding current value
$2,913
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
190Shares Held
73.8MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$226 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$202 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$169 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$160 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$149 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.33B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...